Citigroup’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Sell |
43,883
-101,133
| -70% | -$941K | ﹤0.01% | 3045 |
|
|
2025
Q1 | $976K | Buy |
145,016
+67,780
| +88% | +$456K | ﹤0.01% | 2568 |
|
|
2024
Q4 | $820K | Buy |
77,236
+39,667
| +106% | +$421K | ﹤0.01% | 2726 |
|
|
2024
Q3 | $549K | Buy |
37,569
+15,157
| +68% | +$222K | ﹤0.01% | 2938 |
|
|
2024
Q2 | $271K | Sell |
22,412
-11,009
| -33% | -$133K | ﹤0.01% | 3025 |
|
|
2024
Q1 | $825K | Sell |
33,421
-27,622
| -45% | -$682K | ﹤0.01% | 2507 |
|
|
2023
Q4 | $653K | Buy |
+61,043
| New | +$653K | ﹤0.01% | 2497 |
|
|
2021
Q2 | – | Sell |
-140
| Closed | -$5K | – | 5527 |
|
|
2021
Q1 | $5K | Sell |
140
-95
| -40% | -$3.39K | ﹤0.01% | 5224 |
|
|
2020
Q4 | $2K | Buy |
+235
| New | +$2K | ﹤0.01% | 5105 |
|